Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
复制标题
DOI:
10.1016/j.celrep.2015.12.063
复制
发表时间:
2016-01-26
期刊:
影响因子:
8.8
通讯作者:
Caplen NJ
中科院分区:
文献类型:
--
作者:
Grohar PJ;Kim S;Rangel Rivera GO;Sen N;Haddock S;Harlow ML;Maloney NK;Zhu J;O'Neill M;Jones TL;Huppi K;Grandin M;Gehlhaus K;Klumpp-Thomas CA;Buehler E;Helman LJ;Martin SE;Caplen NJ
Ewing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an assay of EWS-FLI1 activity and genome-wide RNAi screening, we have identified proteins required for the processing of the EWS-FLI1 pre-mRNA. We show Ewing sarcoma cells harboring a genomic breakpoint that retains exon 8 of EWSR1 require the RNA-binding protein HNRNPH1 to express in-frame EWS-FLI1. We also demonstrate the sensitivity of EWS-FLI1 fusion transcripts to the loss-of-function of the U2 snRNP component, SF3B1. Disrupted splicing of the EWS-FLI1 transcript alters EWS-FLI1 protein expression and EWS-FLI1 driven expression. Our results show that the processing of the EWS-FLI1 fusion RNA is a potentially targetable vulnerability in Ewing sarcoma cells.